New protein treatment for liver swelling shows promise in early trial

NCT ID NCT05249374

First seen Mar 26, 2026 · Last updated May 23, 2026 · Updated 6 times

Summary

This early-phase study tested a lab-made version of a natural protein (human serum albumin) in 36 adults with liver cirrhosis and fluid buildup in the belly (ascites). The goal was to check safety and how the body processes the drug at three different doses. Participants received either the test drug or an active control, and researchers monitored side effects and drug levels in the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC ASCITES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hebei Petro China Central Hospital

    Shijiazhuang, Hebei, 050000, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100000, China

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, 337000, China

  • Shenzhen Protgen Co., Ltd.

    Shenzhen, Guangdong, 100084, China

  • Shenzhen Third People's Hospital

    Shenzhen, Guangdong, 518000, China

  • The First Hospital of Changsha

    Changsha, Hunan, 410005, China

  • Yichun People's Hospital

    Yichun, Jiangxi, 336000, China

  • Yiyang Central Hospital

    Yiyang, Hunan, 413000, China

Conditions

Explore the condition pages connected to this study.